Can-Fite BioPharma Ltd. (CANF)
3.28
-0.05
(-1.50%)
USD |
NYAM |
Aug 24, 16:00
3.28
0.00 (0.00%)
After-Hours: 20:00
Can-Fite BioPharma Price : 3.28 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 3.35 | 3.48 | 3.33 | 3.33 | 25645.00 |
| Aug 20, 2026 | 3.47 | 3.47 | 3.35 | 3.35 | 19019.00 |
| Aug 19, 2026 | 3.55 | 3.55 | 3.40 | 3.48 | 19728.00 |
| Aug 18, 2026 | 3.54 | 3.555 | 3.365 | 3.45 | 34060.00 |
| Aug 17, 2026 | 3.41 | 3.58 | 3.383 | 3.58 | 108781.0 |
| Aug 14, 2026 | 3.40 | 3.50 | 3.40 | 3.40 | 16040.00 |
| Aug 13, 2026 | 3.331 | 3.475 | 3.331 | 3.40 | 43653.00 |
| Aug 12, 2026 | 3.47 | 3.501 | 3.34 | 3.44 | 36786.00 |
| Aug 11, 2026 | 3.32 | 3.36 | 3.24 | 3.31 | 18309.00 |
| Aug 10, 2026 | 3.35 | 3.40 | 3.21 | 3.21 | 18762.00 |
| Aug 07, 2026 | 3.490 | 3.490 | 3.39 | 3.44 | 32798.00 |
| Aug 06, 2026 | 3.33 | 3.60 | 3.33 | 3.56 | 103331.0 |
| Aug 05, 2026 | 3.20 | 3.29 | 3.20 | 3.20 | 36632.00 |
| Aug 04, 2026 | 3.22 | 3.28 | 3.19 | 3.19 | 32522.00 |
| Aug 03, 2026 | 3.13 | 3.285 | 3.13 | 3.17 | 33113.00 |
| Jul 31, 2026 | 3.36 | 3.36 | 3.15 | 3.15 | 15517.00 |
| Jul 30, 2026 | 3.215 | 3.32 | 3.181 | 3.28 | 48919.00 |
| Jul 29, 2026 | 3.15 | 3.282 | 3.13 | 3.20 | 25815.00 |
| Jul 28, 2026 | 3.20 | 3.27 | 3.13 | 3.16 | 20966.00 |
| Jul 27, 2026 | 3.25 | 3.25 | 3.15 | 3.15 | 20731.00 |
| Jul 24, 2026 | 3.200 | 3.295 | 3.15 | 3.19 | 36636.00 |
| Jul 23, 2026 | 3.26 | 3.31 | 3.204 | 3.23 | 21874.00 |
| Jul 22, 2026 | 3.35 | 3.40 | 3.30 | 3.30 | 36364.00 |
| Jul 21, 2026 | 3.24 | 3.385 | 3.24 | 3.38 | 26982.00 |
| Jul 20, 2026 | 3.42 | 3.42 | 3.22 | 3.31 | 162750.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioLineRx Ltd. | 2.80 |
| XTL Biopharmaceuticals Ltd. | 2.53 |
| Kamada Ltd. | 8.42 |
| Galmed Pharmaceuticals Ltd. | 4.02 |
| Revium Recovery, Inc. | 1.43 |
Price Related Metrics
| PS Ratio | 7.557 |
| Price to Book Value | 2.381 |
| Earnings Yield | -379.6% |
| Market Cap | 4.298M |